Michelle Palmieri

<i>SMAD2</i>,<i>SMAD3</i>and<i>SMAD4</i>Mutations in Colorectal Cancer

Nicholas I. Fleming, Robert N. Jorissen, Dmitri Mouradov et al. · Cancer Research · 2012 · 322 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +13

mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice

Stefan Thiem, Thomas P. Pierce, Michelle Palmieri et al. · Journal of Clinical Investigation · 2013 · 108 citations · Full text

Inflammation, Cytokine, Mtor Complex 1 +12

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

Zilu Wang, Matteo Burigotto, Sabrina Ghetti et al. · Cancer Discovery · 2023 · 79 citations · Full text

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Enric Domingo, Carme Camps, Pamela J. Kaisaki et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 75 citations · Full text

Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes

David S. Williams, Dmitri Mouradov, Robert N. Jorissen et al. · Gut · 2018 · 73 citations